Search

HIV-positive people are generally at heightened risk for cardiovascular disease because of a number of contributing risk factors, including the following: . ...

Marijuana is a widely used substance, particularly among some HIV-positive people who use it to reduce chronic pain, nausea and anxiety/depression and to ...

A number of clinical trials are underway to study therapies that can help reduce inflammation and have other beneficial effects in people on HIV treatment ...

PEI was the first province in Canada to launch a province-wide model for hepatitis C care.. 93 patients started treatment in the first year, compared to only ...

This resource provides basic information about HIV testing and is written for people who are thinking about getting tested for HIV or have questions about HIV testing.

In this chapter, we identify a host agency’s program monitoring and evaluation responsibilities.

In this chapter, we explore issues related to integrating peer health navigators onto teams in healthcare settings such as hospitals and clinics.

In this chapter, we explore the ongoing community engagement and development work needed to support peer health navigators to work with external community-based agencies.

As more people start HIV treatment, researchers are exploring ways to cut costs. Single tablets can be replaced by a few pills comprising cheaper generic drugs. ...

Ontario study finds people with HIV are more likely to use mental health services. People with HIV are four times more likely to seek emergency mental health ...

Triumeq is the brand name of a pill containing the following three anti-HIV medicines: . dolutegravir. abacavir. 3TC Triumeq is a complete HIV treatment - ...

Biktarvy is a new regimen in one pill containing the following anti-HIV drugs: . bictegravir – 50 mg. TAF (tenofovir alafenamide) – 25 mg. FTC ...